首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1489214

全球体外受精市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global In Vitro Fertilization Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球体外受精市场需求预计将从 2023 年的 7.8289 亿美元增至 2032 年的近 14.9472 亿美元，2024-2032 年研究期间复合年增长率为 7.45%。

体外受精（IVF）是一种用于帮助不孕症的个人或夫妇实现怀孕的生殖技术。它包括在实验室环境中在体外用精子使卵子受精，并将所得胚胎移植到子宫中。建议体外受精的原因可能有多种，包括输卵管阻塞、男性不孕、高龄产妇或不明原因不孕。这个过程通常包括卵巢刺激以产生多个卵子、透过经阴道超音波引导抽吸取卵、在培养皿中使取出的卵子受精、胚胎培养和选择以及胚胎移植。体外受精为面临自然受孕挑战的个人带来了希望，其成功率受年龄、生殖健康和治疗方案等因素的影响。

市场动态

由于孕产妇年龄增长、生活方式改变和生殖健康障碍等因素，全球不孕症盛行率不断上升，推动了对体外受精的需求。随着夫妻和个人寻求克服不孕症挑战的解决方案，试管受精手术为怀孕提供了可行的选择。此外，体外受精技术、实验室方案和胚胎培养系统的进步提高了成功率和结果，增强了人们对体外受精作为治疗选择的信心。此外，IVF 服务范围的不断扩大，包括植入前基因检测 (PGT)、卵子冷冻和胚胎选择技术，正在扩大市场吸引力并推动不同患者群体的采用。此外，LGBTQ+夫妇、选择的单亲父母以及推迟生育的个人对试管受精手术的接受度不断提高，这正在扩大市场潜力，并推动生育治疗和服务的创新。然而，有关使用辅助生殖技术的监管限制和伦理考虑，以及体外受精治疗的高成本，可能会挑战未来几年体外受精市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球体外受精市场的各个细分市场进行了包容性评估。体外受精产业的成长和趋势为本研究提供了整体方法。

市场区隔

体外受精市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

装置
试剂和介质
配件

按週期

新的非捐款週期
冷冻非供体 IVF 週期
冷冻供体 IVF 週期
新鲜捐赠者 IVF 週期

按类型

传统体外受精
IVF 与 ICSI
使用捐赠卵子进行体外受精

按最终用户

生育诊所
医院及手术中心
冷冻库和研究所

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲体外受精市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。体外受精市场的主要参与者包括 Vitrolife AB、Cook Medical、Thermo Fisher Scientific Inc.、Merck KGAA、Ovascience Inc.、CooperSurgical、EMD Serono Inc.、Genea Ltd.、Rocket Medical PLC、Fertility Focus Ltd.。格局的整体看法，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品分類的市场吸引力分析
- 按週期的市场吸引力分析
- 按类型分類的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球体外受精市场分析：依产品分类

概述（按产品）
历史和预测数据
按产品分析
装置
试剂和介质
配件

第 6 章：全球体外受精市场分析：按週期

按週期概览
历史和预测数据
按週期分析
新的非捐款週期
冷冻非供体 IVF 週期
冷冻供体 IVF 週期
新鲜捐赠者 IVF 週期

第 7 章：全球体外受精市场分析：按类型

按类型概述
历史和预测数据
按类型分析
传统体外受精
IVF 与 ICSI
使用捐赠卵子进行体外受精

第 8 章：全球体外受精市场分析：依最终使用者分类

最终用户概述
历史和预测数据
最终用户分析
生育诊所
医院及手术中心
冷冻库和研究所

第 9 章：全球体外受精市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：体外受精公司的竞争格局

体外受精市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Vitrolife AB

公司简介
公司收入
产品
最近的发展

Cook Medical

公司简介
公司收入
产品
最近的发展

Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

Merck KGAA

公司简介
公司收入
产品
最近的发展

Ovascience Inc.

公司简介
公司收入
产品
最近的发展

CooperSurgical

公司简介
公司收入
产品
最近的发展

EMD Serono Inc.

公司简介
公司收入
产品
最近的发展

Genea Ltd.

公司简介
公司收入
产品
最近的发展

Rocket Medical PLC

公司简介
公司收入
产品
最近的发展

Fertility Focus Ltd

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114516

The global demand for In Vitro Fertilization Market is presumed to reach the market size of nearly USD 1494.72 Million by 2032 from USD 782.89 Million in 2023 with a CAGR of 7.45% under the study period 2024-2032.

In vitro fertilization (IVF) represents a reproductive technology used to assist individuals or couples with infertility in achieving pregnancy. It includes fertilizing an egg with sperm outside the body in a laboratory setting and transferring the resulting embryos into the uterus. IVF may be recommended for different reasons, including blocked fallopian tubes, male infertility, advanced maternal age, or unexplained infertility. The process typically includes ovarian stimulation to produce multiple eggs, egg retrieval via transvaginal ultrasound-guided aspiration, fertilization of retrieved eggs in a culture dish, embryo culture and selection, and embryo transfer. IVF offers hope for individuals facing challenges conceiving naturally, with success rates influenced by factors such as age, reproductive health, and treatment protocols.

MARKET DYNAMICS

The increasing prevalence of infertility worldwide, attributed to factors such as advancing maternal age, lifestyle changes, and reproductive health disorders, is driving demand for in vitro fertilization. As couples and individuals seek solutions to overcome infertility challenges, IVF procedures offer a viable option for achieving pregnancy. Additionally, advancements in IVF techniques, laboratory protocols, and embryo culture systems have enhanced success rates and outcomes, boosting confidence in IVF as a treatment option. Furthermore, the expanding scope of IVF services, including preimplantation genetic testing (PGT), egg freezing, and embryo selection technologies, is widening the market appeal and driving adoption among diverse patient populations. Moreover, the growing acceptance of IVF procedures among LGBTQ+ couples, single parents by choice, and individuals delaying parenthood is expanding the market potential and driving innovation in fertility treatments and services. However, regulatory restrictions and ethical considerations regarding the use of assisted reproductive technologies, along with the high cost of in vitro fertilization treatments, may challenge the in vitro fertilization market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In Vitro Fertilization. The growth and trends of In Vitro Fertilization industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In Vitro Fertilization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Equipment
Reagents & Media
Accessories

By Cycle

Fresh Non-donor Cycle
Frozen Non-donor IVF Cycle
Frozen Donor IVF Cycle
Fresh Donor IVF Cycle

By Type

Conventional IVF
IVF with ICSI
IVF with Donor Eggs

By End-user

Fertility Clinics
Hospitals & Surgical Centers
Cryobanks & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Fertilization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Fertilization market include Vitrolife AB, Cook Medical, Thermo Fisher Scientific Inc., Merck KGAA, Ovascience Inc., CooperSurgical, EMD Serono Inc., Genea Ltd., Rocket Medical PLC, Fertility Focus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VITRO FERTILIZATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Cycle
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Equipment Historic and Forecast Sales By Regions
5.5. Reagents & Media Historic and Forecast Sales By Regions
5.6. Accessories Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY CYCLE

6.1. Overview By Cycle
6.2. Historical and Forecast Data
6.3. Analysis By Cycle
6.4. Fresh Non-donor Cycle Historic and Forecast Sales By Regions
6.5. Frozen Non-donor IVF Cycle Historic and Forecast Sales By Regions
6.6. Frozen Donor IVF Cycle Historic and Forecast Sales By Regions
6.7. Fresh Donor IVF Cycle Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY TYPE

7.1. Overview By Type
7.2. Historical and Forecast Data
7.3. Analysis By Type
7.4. Conventional IVF Historic and Forecast Sales By Regions
7.5. IVF with ICSI Historic and Forecast Sales By Regions
7.6. IVF with Donor Eggs Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Fertility Clinics Historic and Forecast Sales By Regions
8.5. Hospitals & Surgical Centers Historic and Forecast Sales By Regions
8.6. Cryobanks & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO FERTILIZATION COMPANIES

10.1. In Vitro Fertilization Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO FERTILIZATION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Vitrolife AB
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Cook Medical
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Merck KGAA
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Ovascience Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. CooperSurgical
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. EMD Serono Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Genea Ltd.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Rocket Medical PLC
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Fertility Focus Ltd
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments